Funded Startups in Monrovia
Among the five most recent funded entries tied to Monrovia, California, the largest disclosed round is Xencor’s $201M on 2024-09-11, which dwarfs the next-…
Among the five most recent funded entries tied to Monrovia, California, the largest disclosed round is Xencor’s $201M on 2024-09-11, which dwarfs the next-largest disclosed amount of $25M (SiLC Technologies, 2023-11-15). The same table also shows a clear sector skew: three of the five companies are in Biotechnology (eXoZymes on 2025-04-10, Xencor on 2024-09-11, and SiLC Technologies on 2023-11-15), while the remaining two split across Artificial Intelligence (AcuraStem, $4M on 2024-09-03) and Data and Analytics (VivoAquatics, $2M on 2023-01-25).
Timing is concentrated in a late-2024 window: three rounds fall between 2024-09-03 and 2024-09-11 (AcuraStem at $4M on 2024-09-03, Xencor at $201M on 2024-09-11), with the list spanning 2023-01-25 (VivoAquatics) through 2025-04-10 (eXoZymes). Stage labeling is also heavily opaque here: four of five entries are marked “Series Unknown,” with only SiLC Technologies showing “Series A” ($25M on 2023-11-15).
Most recent rounds
5 shownRelated listings
Frequently asked
What’s the largest disclosed round in Monrovia here, and how does it stack up against the rest?
Xencor’s $201M disclosed round on 2024-09-11 is the dominant outlier, far above the next-largest disclosed amount of $25M (SiLC Technologies on 2023-11-15). The smallest disclosed round is $2M (VivoAquatics on 2023-01-25), which sits well below the mid-$ millions entries.
Are any sectors over-represented in this Monrovia slice?
Biotechnology is over-represented at three of five companies (eXoZymes on 2025-04-10 for $300K, Xencor on 2024-09-11 for $201M, and SiLC Technologies on 2023-11-15 for $25M). The remaining two are AcuraStem (Artificial Intelligence, $4M on 2024-09-03) and VivoAquatics (Data and Analytics, $2M on 2023-01-25).
Which entries closed in the most recent period shown, and is there a tight date cluster?
Within the date window shown (from 2023-01-25 through 2025-04-10), there is a tight late-2024 cluster: AcuraStem closed on 2024-09-03 ($4M) and Xencor followed on 2024-09-11 ($201M). The rest are more spread out across 2023-11-15 (SiLC Technologies, $25M) and 2025-04-10 (eXoZymes, $300K).
How does stage information present itself in this list?
Stage is listed as “Series Unknown” for four of five entries, including eXoZymes ($300K on 2025-04-10), Xencor ($201M on 2024-09-11), AcuraStem ($4M on 2024-09-03), and VivoAquatics ($2M on 2023-01-25). Only SiLC Technologies is labeled “Series A” with $25M on 2023-11-15.
Are there notable outliers beyond deal size (sector or relative scale)?
Deal size is the primary outlier: Xencor’s $201M (2024-09-11) is vastly larger than every other disclosed round in the five-row set, including SiLC Technologies at $25M (2023-11-15) and AcuraStem at $4M (2024-09-03). Sector-wise, the list is still dominated by Biotechnology, but the scale gap is concentrated in the Xencor entry rather than being spread across multiple companies.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.